ACLARUBICIN for Chemotherapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where ACLARUBICIN was used for Chemotherapy.
Most Reported Side Effects for ACLARUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 80 | 25.5% | 3 | 20 |
| Bone marrow failure | 73 | 23.3% | 14 | 7 |
| Off label use | 38 | 12.1% | 6 | 4 |
| Nausea | 35 | 11.2% | 1 | 2 |
| Infection | 26 | 8.3% | 2 | 1 |
| Acute myeloid leukaemia | 24 | 7.6% | 11 | 8 |
| Product use in unapproved indication | 22 | 7.0% | 1 | 1 |
| Platelet count decreased | 21 | 6.7% | 5 | 9 |
| Febrile neutropenia | 19 | 6.1% | 8 | 5 |
| Pneumonia | 19 | 6.1% | 11 | 5 |
| Thrombocytopenia | 18 | 5.7% | 4 | 4 |
| Anaemia | 17 | 5.4% | 3 | 3 |
| Alopecia | 16 | 5.1% | 0 | 0 |
| Diarrhoea | 16 | 5.1% | 2 | 2 |
| Drug-induced liver injury | 16 | 5.1% | 2 | 0 |
Other Indications for ACLARUBICIN
Acute myeloid leukaemia (168)
Myelodysplastic syndrome (18)
Acute myeloid leukaemia refractory (15)
Acute leukaemia (11)
Acute myeloid leukaemia recurrent (11)
T-cell type acute leukaemia (10)
Product used for unknown indication (9)
Myelodysplastic syndrome with excess blasts (8)
Acute promyelocytic leukaemia (7)
B-cell lymphoma (6)
Other Drugs Used for Chemotherapy
CYCLOPHOSPHAMIDE (3,372)
DOCETAXEL (2,134)
CARBOPLATIN (1,902)
DOXORUBICIN (1,756)
VINCRISTINE (1,743)
PACLITAXEL (1,425)
OXALIPLATIN (1,423)
METHOTREXATE (1,380)
CYTARABINE (1,355)
ETOPOSIDE (1,246)